Angiodynamics (ANGO) Divestments (2023 - 2024)
Angiodynamics (ANGO) reported Divestments of $34.5 million for Q1 2024, down 65.5% quarter-over-quarter from $100.0 million in Q3 2023.
Angiodynamics (ANGO) Divestments (2023 - 2024) Analysis & Trends
Angiodynamics has reported Divestments for 2 years, with the latest figure at $34.5 million in Q1 2024.
- For the quarter ending Q1 2024, Divestments changed N/A year-over-year to $34.5 million; the trailing twelve-month figure through Nov 2024 stood at $34.5 million (down 65.5% YoY), and the FY2024 full-year result was $134.5 million, changed N/A from the prior year.
- Divestments for Q1 2024 stood at $34.5 million, down from $100.0 million in the prior quarter.
- The five-year high for Divestments was $100.0 million in Q3 2023, with the low at $34.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Angiodynamics | 505.81 Mn | 468.00 Mn | 41.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 29, 2024 | 34.50 Mn |
| Aug 31, 2023 | 100.00 Mn |